Its three indications are all in adults with type 2 diabetes: improving glycemic control as an adjunct to diet and exercise, reducing the risk of major adverse cardiovascular events in those with established cardiovascular disease, and reducing the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in those with chronic kidney disease
Routes of Administration Like many research peptides, injection of BPC-157 has historically been the favored route of administration due to the compounds instability and consequent low oral bioavailability
Seasonal adaptation strategies help maintain consistency year-round despite changing weather, schedules, and activity patterns that affect motivation and feasibility
These medications were first used in diabetes management because GLP-1 causes the release of insulin, which helps control blood sugar, says Muhammad Feteiha, MD, general and bariatric surgeon at Atlantic Health System and board certified in Obesity Medicine